Skip to main content
Tech.euFundingExplorerBeta

Immunos Therapeutics

ImmunOs Therapeutics is a clinical-stage biotechnology company.

Immunos Therapeutics has raised €92M across 3 funding rounds from 14 investors, most recently a Series C round in Sep 2024. Based in Schlieren, Switzerland; founded 2014; active in Healthtech. Data as of 28 Oct 2026.

Total raised
€92M
€91,835,821
Funding rounds
3
Investors
14
distinct backers
Active since
2019-10
latest 2024-09

Funding by year

EUR raised per year
Immunos Therapeutics — funding by year — interactive chart.
Data table
Immunos Therapeutics — funding by year
2019€14M
2022€68M
2024€9.9M

Signals

High confidence
Raise-next likelihood32
base rate 50% for Series C
  • ▼ In typical raise window
  • ▼ Down/flat last round
  • ▼ Low backer re-investment
Exit likelihood11
base rate 11% (2+ rounds)
  • ▲ €30M+ raised
  • ▼ No recent equity round (debt-only or quiet)

Timing: in window vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

3 rounds

Similar companies

same sector or country

Global coverage: FundingData